IVF

INVO Fertility, Inc.

Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. NV· CIK 0001417926 Healthcare & Medical Devices

$0.6161 +0.05 (+8.09%)

Oct 27 4:00 PM ET · prev $0.5700

Market cap

$2.6M

Nano cap

Median target

$20.00

+3146% · range $20.00–20.00

Next earnings

Nov 23

in 27 days · EPS est. −$5.20

1 year

−97.0%

from $20.60 · Oct 28

30 days

−34.0%

from $0.9340

52-week range

$0.5330–22.76

−97% from high · low Oct 22

Avg volume 20D

108.9K

shares / day

Short interest

26.5K

≈0.6% of shares · −47.2%

Days to cover

1.0

at average volume

Filing reports

analyzed by SecBot

SecBot read BEARISH 6 reports · 90 days

Balance 4 bearish · 0 bullish · 2 neutral oldest → newest, height = score

Avg score

·High conf. 1/6 ·Next Earnings date, Nov 23, 2026

Strongest BEARISH Glenbrook Capital Management filed an amended Schedule 13G reporting a reduction in its stake in INVO…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Feb 24 INVO Fertility, Inc. completed the acquisition of Family Beginnings,…
R Jun 2 INVO Fertility filed an 8-K announcing that its previously issued un…
R Aug 17 INVO Fertility reported Q2 2026 revenue of $2.18M (+17% YoY) and net…
R Aug 28 INVO Fertility filed an 8-K disclosing an investor presentation for…
X Aug 31 Short interest jumps 60.9% to 367.5K
X Sep 15 Short interest falls 47.3% to 193.7K
X Sep 30 Short interest falls 74.1% to 50.1K
X Oct 15 Short interest falls 47.2% to 26.5K

Signal stack

Where each data set points today.

Short sellersCOVERING

Short interest −47.2% to 26.5K shares. 1.0 days to cover, ≈0.6% of shares.
TrendDOWNTREND

30% below its 50-day average. New closing low $0.5330 on Oct 22.

Who's buying

13F

Top holder	Shares	Value
SUSQUEHANNA INTERNATIONAL GROUP, LLP	11,463	$21.8K
DANSKE BANK A/S	1	$2.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12-month targets · 1 analysts

$0.6161 $20.00 $20.00 $20.00

Price is below the lowest target. Median implies +3146%.Targets as of Oct 27, 2026.

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 27, 2026 Press

🔒 Fresh report (last 24h), subscribers only

Oct 27, 2026 Activist

🔒 Fresh data, subscribers only

Oct 9, 2026 SEC

Glenbrook Capital Management filed an amended Schedule 13G reporting a reduction in its stake in INVO Fertility, Inc…

SC 13G/A — Impact 4/10

Aug 28, 2026 SEC

INVO Fertility filed an 8-K disclosing an investor presentation for the H.C. Wainwright conference and providing an…

8-K — Impact 6/10

Aug 17, 2026 SEC

INVO Fertility reported Q2 2026 revenue of $2.18M (+17% YoY) and net income of $0.9M, swinging from a $(3.6)M loss in…

8-K — Impact 4/10

Jun 2, 2026 Press

INVO Fertility disclosed a Nasdaq delinquency notice for late filing of its 10-K (FY2025) and 10-Q (Q1 2026). The 10-K…

Impact 6/10

Earnings setup

Estimates

Nov 23

reports in 27 days

−$5.20

EPS estimate, this quarter

Current-quarter EPS estimate

$0.000

90d

$0.000

60d

$0.000

30d

$0.000

−$5.200

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$5.20	-$5.20–-$5.20	—	$2.7M
Next Q	-$4.40	-$4.40–-$4.40	—	$3.3M
Current FY	-$23.20	-$23.20–-$23.20	+80.3%	$10.4M
Next FY	-$8.00	-$8.00–-$8.00	+96.4%	$16.5M